Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1464 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Seventure Partners. (12/14/17). "Press Release: Seventure Partners’ Microbiome Portfolio is Reaching Critical Milestones in Current and Upcoming Clinical Trials". Paris. 2017-12-14
Arbiom Inc.. (12/14/17). "Press Release: Arbiom Led Consortium Receives €4M Refundable Loan from ADEME to Upscale Its Technology Allowing the Production of Sugars and Lignin from Forestry Material". Évry. 2017-12-14
Servier. (12/13/17). "Press Release: Preliminary Data from Servier and Pfizer’s UCART19 Product Candidate Shows High Complete Remission Rate". 2017-12-13
Sanofi S.A.. (12/11/17). "Press Release: FDA Approves Sanofi’s Admelog (insulin lispro injection)". Paris. 2017-12-11
Discngine S.A.S.. (12/11/17). "Press Release: Discngine Raises €1.1 Million ($1.3M) in Series A Funding Round". Paris. 2017-12-11
Erytech Pharma. (12/8/17). "Press Release: Erytech Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML". Lyon. 2017-12-08
Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. 2017-12-07
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". 2017-12-06
Robocath S.A.S.. (12/6/17). "Press Release: Robocath Raises a Total of €6.4 million ($7.6M) in 2017". 2017-12-06
Genoscience Pharma S.A.S.. (12/6/17). "Press Release: Genoscience Pharma Receives FDA Approval for Phase Ib/IIa Study of GNS561 in Liver Cancer". Marseille. 2017-12-06
Advicenne S.A.. (12/5/17). "Press Release: Advicenne Raises €27 Million in Successful IPO on Euronext Paris [THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISSEMINATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY TO THE USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes. 2017-12-05
Agendia. (12/5/17). "Press Release: Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study". Irvine, CA, Amsterdam & Paris. 2017-12-05
Sanofi S.A.. (12/4/17). "Press Release: Sanofi’s Toujeo Met Main Objective in Head-to-head Study versus Insulin Degludec". Paris. 2017-12-04
Leti. (12/4/17). "Press Release: Leti Researcher Reappointed Head of the European Technology Platform for Nanomedicine". 2017-12-04
Cellectis S.A.. (12/4/17). "Press Release: Cellectis Appoints Elsy Boglioli to Executive Vice President, Strategy and Corporate Development". 2017-12-04
Apix Analytics S.A.. (12/1/17). "Press Release: Apix Analytics Raises 8 Million Euros to Accelerate Its International Development". Grenoble. 2017-12-01
Leti. (11/30/17). "Press Release: Leti Develops Meg Technology To Improve Diagnosis Of Epilepsy and Guide Surgeons During Brain Surgery". 2017-11-30
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Cellectis S.A.. (11/20/17). "Press Release: Cellectis Demonstrates Fine and Predictable Tuning of TALEN Gene Editing Targeting to Improve T-cell Adoptive Immunotherapy". New York, NY. 2017-11-20
Erytech Pharma. (11/15/17). "Press Release: Erytech Announces Commencement of Trading of ADSs on Nasdaq and Full Exercise of Underwriters’ Option, Bringing Gross Proceeds of Global Offering to $144 Million [NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA OR JA 2017-11-15
Cellectis S.A.. (11/13/17). "Press Release: Cellectis Reports Financial Results for Third Quarter and First Nine Months of 2017". New York, NY. 2017-11-13
Erytech Pharma. (11/10/17). "Press Release: Erytech Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market [Not for distribution in Australia, Canada and Japan]". Lyon. 2017-11-10
Sanofi S.A.. (11/9/17). "Press Release: Sanofi, Principia Agree to Develop Multiple Sclerosis Drug Candidate". Paris & South San Francisco, CA. 2017-11-09
Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. 2017-11-09
Cerenis Therapeutics S.A.. (11/8/17). "Press Release: Cerenis Therapeutics Acquires Lypro Biosciences Expanding Its HDL Strategy into Immuno-oncology and Chemotherapeutic Drug Delivery". Toulouse & Lakeland, US. 2017-11-08
Horama S.A.. (11/8/17). "Press Release: Horama Raises €19 million in a Series B Financing Round". Paris. 2017-11-08
Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. 2017-11-07
Cellectis S.A.. (11/6/17). "Press Release: FDA Lifts Clinical Hold on Cellectis Phase 1 Clinical Trials with UCART123 in AML and BPDCN". New York, NY. 2017-11-06
Erytech Pharma. (11/6/17). "Press Release: Erytech Announces Launch of Proposed Global Offering and NASDAQ Listing [Not for distribution in Australia, Canada and Japan]". Lyon. 2017-11-06
Erytech Pharma. (11/6/17). "Press Release: Erytech Reports Third Quarter 2017 Financial Results and Provides Business Update". Lyon. 2017-11-06
Euronext N.V.. (10/30/17). "Press Release: Theranexus Takes Its First Steps on Euronext Growth". Paris. 2017-10-30
Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel. 2017-10-28
TxCell S.A.. (10/25/17). "Press Release: TxCell Renegotiates OCABSA Financing Option to Extend Cash Runway [Not for distribution in the United States of America, Canada, Australia and Japan]". Valbonne. 2017-10-25
Novartis AG. (10/25/17). "Press Release: Novartis Confirms Leadership in Multiple Sclerosis (MS) with Scientific Advancements and New Data presented at ECTRIMS". Basel. 2017-10-25
DBV Technologies S.A.. (10/20/17). "Press Release: DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut Allergic Patients Four to 11 Years of Age". 2017-10-20
Servier. (10/19/17). "Press Release: Servier Establishes Strategic Research Alliance with Harvard University". 2017-10-19
TxCell S.A.. (10/19/17). "Press Release: Financial Information for the 3rd Quarter of 2017". Valbonne. 2017-10-19
Pharnext S.A.. (10/19/17). "Press Release: First-Half 2017". Paris. 2017-10-19
bioMérieux S.A.. (10/18/17). "Press Release: bioMérieux – Business Review for the Nine Months ended September 30, 2017". 2017-10-18
Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge. 2017-10-18
Bryan, Garnier & Co., Ltd.. (10/17/17). "Press Release: Bryan, Garnier & Co Strengthens Its Investment Banking Team with the Hiring of Marc-Antoine Janny as Vice President". Paris. 2017-10-17
Onxeo S.A.. (10/17/17). "Press Release: Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm". Paris. 2017-10-17
Mutabilis S. A.. (10/17/17). "Press Release: Mutabilis Joins the European ENABLE Consortium to Fight Antibiotic Resistance". Paris. 2017-10-17
Sanofi S.A.. (10/16/17). "Press Release: Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis". Paris & Tarrytown, NY. 2017-10-16
Euronext N.V.. (10/13/17). "Press Release: Biom’up Lists on Euronext Paris to Finance Its Development". Paris. 2017-10-13
Sanofi S.A.. (10/12/17). "Press Release: Sanofi Invests €170 Million in New Vaccine Production Facility in France". Paris. 2017-10-12
Bryan, Garnier & Co., Ltd.. (10/11/17). "Press Release: Bryan Garnier & Co Acts as Sole Global Coordinator for Biom'Up's Landmark Euronext IPO, Raising up to €44 Million including Greenshoe". 2017-10-11
Erytech Pharma. (10/10/17). "Press Release: Erytech Announces Resubmission of European Marketing Authorization Application for Graspa in Acute Lymphoblastic Leukemia". Lyon. 2017-10-10
Bryan, Garnier & Co., Ltd.. (10/10/17). "Press Release: Bryan, Garnier & Co Grows Its Equity Research Healthcare Team". Paris. 2017-10-10
Bryan, Garnier & Co., Ltd.. (10/9/17). "Press Release: Bryan, Garnier & Co Grows Its Healthcare Franchise with the Hiring of Dr Anne Moore". Paris. 2017-10-09
Erytech Pharma. (10/6/17). "Press Release: Erytech Files Registration Statement for Proposed Initial Public Offering in the United States". Lyon. 2017-10-06
Servier. (10/4/17). "Press Release: Servier Opts for Saclay as Its Future Research Centre". 2017-10-04
Cellectis S.A.. (10/4/17). "Press Release: Mathieu Simon, M.D. Cellectis’ EVP & Chief Operating Officer, to Serve as Interim Chief Medical Officer". New York, NY. 2017-10-04
Global Bioenergies S.A.. (10/3/17). "Press Release: Global Bioenergies Strengthens Its Management Team". Évry. 2017-10-03
Global Bioenergies S.A.. (10/2/17). "Press Release: Publication of the half-year results to 30/06/2017. Net Loss for the Group of €7.8 Million in the First Half of 2017". Évry. 2017-10-02
Transgene S.A.. (10/2/17). "Press Release: Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors". Strasbourg & Belfast. 2017-10-02
Abivax S.A.. (9/28/17). "Press Release: Abivax’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial". Paris. 2017-09-28
Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. 2017-09-28
Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". 2017-09-27
LNC Therapeutics. (9/27/17). "Press Release: LNC Therapeutics Raises € 6.5 Million and Reinforces Its R&D in the Microbiota Field". Bordeaux. 2017-09-27
Eligo Bioscience. (9/26/17). "Press Release: Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome". London. 2017-09-26
Transgene S.A.. (9/21/17). "Press Release: Transgene Launches Invir.IOŹ, its Integrated Platform for the Next Generation of Multifunctional Oncolytic Viruses". Strasbourg. 2017-09-21
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
BioSerenity. (9/20/17). "Press Release: BioSerenity, Digital Health Champion, Raises 15 Million Euros". Paris. 2017-09-20
Abivax S.A.. (9/20/17). "Press Release: Abivax Receives French Regulatory Approval to Begin Clinical Trial of ABX464 in Ulcerative Colitis". Paris. 2017-09-20
Enterome S.A.. (9/20/17). "Press Release: Enterome to Move its Research Laboratories to Genopole, France’s First Biocluster". Évry. 2017-09-20
Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. 2017-09-19
Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. 2017-09-18
Transgene S.A.. (9/13/17). "Press Release: First Half-year 2017 in Line with Our Objectives – All Clinical Programs Progressing and New Collaboration Agreements Signed". Strasbourg. 2017-09-13
DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris. 2017-09-12
Erytech Pharma. (9/11/17). "Press Release: Erytech Reports First Half 2017 Financial Results and Provides Business Update". Lyon. 2017-09-11
Transgene S.A.. (9/11/17). "Press Release: Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)". Strasbourg. 2017-09-11
Roche. (9/11/17). "Press Release: Onxeo Announces Top-line Results from ReLive Phase III Study of Livatag in Advanced Hepatocellular Carcinoma". Paris. 2017-09-11
Erytech Pharma. (9/8/17). "Press Release: Erytech Announces Positive Full Results from Phase 2b Study of Eryaspase in Combination with Chemotherapy for Treatment of Metastatic Pancreatic Cancer in Second-Line". Lyon. 2017-09-08
HalioDx S.A.S.. (9/8/17). "Press Release: HalioDx Announces Clinical Collaboration with PRODIGE to Evaluate Immunoscore in IDEA1 Stage III Colon Cancer Study". Marseille. 2017-09-08
OSE Immunotherapeutics S.A.. (9/7/17). "Press Release: OSE Immunotherapeutics Reports on First-Half 2017 Financial Results and Provides Update on Clinical Advances of its Product Portfolio". Nantes. 2017-09-07
IntegraGen S.A.. (9/7/17). "Press Release: IntegraGen Announces CE-IVD Marking of miRpredX 31-3p Kit which Predicts Patient Response to anti-EGFR Therapy in RAS Wild-Type Metastatic Colorectal Cancer". Évry. 2017-09-07
HalioDx S.A.S.. (9/7/17). "Press Release: HalioDx Participates in Two Grants-supported Academic Collaborations". Marseille. 2017-09-07
Medicen Paris Region. (9/7/17). "Press Release: BioWin and Medicen Focus on Developing Medical Imaging and Digital Health in Europe". Gosselies & Paris. 2017-09-07
Servier. (9/5/17). "Press Release: Servier and Institut Curie Extend Duration and Scope of Partnership in Fight against Cancer". 2017-09-05
Cellectis S.A.. (9/4/17). "Press Release: Cellectis Reports Clinical Hold of UCART123 Studies". New York, NY. 2017-09-04
bioMérieux S.A.. (8/30/17). "Press Release: First-Half 2017 Results". Marcy l’Étoile. 2017-08-30
Alimera Sciences, Inc.. (8/29/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in France". Atlanta, GA. 2017-08-29
DBV Technologies S.A.. (8/29/17). "Press Release: DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut". Montrouge. 2017-08-29
Sanofi S.A.. (8/28/17). "Press Release: Sanofi Completes the Acquisition of Protein Sciences". Paris. 2017-08-28
Servier. (8/24/17). "Press Release: WeHealth by Servier, Servier’s E-health Department, Teams Up with CardioRenal to Provide Better Support to Heart Failure Patients". 2017-08-24
Cellectis S.A.. (8/17/17). "Press Release: Cellectis’ UCART123 Administered to First Patient with BPDCN in Phase I Clinical Trial at MD Anderson Cancer Center". New York, NY. 2017-08-17
Nicox S.A.. (8/15/17). "Press Release: Nicox Announces €26.25 Million Financing [Not for distribution in or into the United States of America, Canada, Japan or Australia, except as permitted by applicable law]". Sophia Antipolis. 2017-08-15
Genkyotex S.A.. (8/3/17). "Press Release: Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts". Archamps & Geneva. 2017-08-03
DBV Technologies S.A.. (8/2/17). "Press Release: DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-allergic Patients One to Three Years of Age". 2017-08-02
Cellectis S.A.. (8/2/17). "Press Release: Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2017". New York, NY. 2017-08-02
GenSight Biologics S.A.. (8/1/17). "Press Relase: GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy". Paris. 2017-08-01
Valneva S.E.. (8/1/17). "Press Release: Valneva Announces Expansion of its Management Board – Strengthening Senior Management for Future Growth". Lyon. 2017-08-01
GenSight Biologics S.A.. (7/28/17). "Press Relase: GenSight Biologics Reports Interim Financial Results for the First Half of 2017". Paris. 2017-07-28
Genkyotex S.A.. (7/27/17). "Press Release: Genkyotex Provides Business Update for Q2 2017". Archamps. 2017-07-27
TxCell S.A.. (7/26/17). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2017". Valbonne. 2017-07-26
Cellectis S.A.. (7/25/17). "Press Release: Calyxt Announces Full Exercise of Over-allotment Option and Closing of Its Initial Public Offering". St. Paul, MN & New York, NY. 2017-07-25
Valneva S.E.. (7/24/17). "Press Release: Valneva Receives FDA Fast Track Designation for Its Lyme Disease Vaccine Candidate VLA15". Lyon. 2017-07-24
Cellectis S.A.. (7/24/17). "Press Release: Cellectis Granted Patent for CRISPR Use in T-Cells". New York, NY. 2017-07-24
Sanofi S.A.. (7/21/17). "Press Release: Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis". Paris & Tarrytown, NY. 2017-07-21
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top